BioCentury
ARTICLE | Company News

Nodality, Pfizer deal

August 13, 2012 7:00 AM UTC

Nodality and Pfizer partnered to use Nodality's Single Cell Network Profiling (SCNP) technology to develop Pfizer's autoimmune compounds, with an initial focus on lupus. The technology analyzes intrac...